Literature DB >> 3780847

Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release.

G Maura, M Raiteri.   

Abstract

The effects of 5-hydroxytryptamine (5-HT) on the release of [3H]acetylcholine ([3H]ACh) from rat hippocampal nerve endings were investigated using synaptosomes labelled with [3H]choline and depolarized in superfusion with 15 mM KCl. The release of [3H]ACh was concentration dependently inhibited by exogenous 5-HT. The concentration-response curve of 5-HT was shifted to the right in a parallel way by methiothepin. The 5-HT2 antagonists ketanserin or methysergide did not antagonize the effect of 5-HT. The 5-HT1 agonist 5-methoxy-3-[1,2,3,6-tetrahydropyridin-4-yl]-1H-indole (RU 24969) mimicked 5-HT, whereas the 5-HT1A selective agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) was ineffective. When used as a 5-HT1A/5-HT1B antagonist, (-)propranolol antagonized 5-HT whereas spiperone (a 5-HT1A displacer) did not. The 5-HT1C selective antagonist mesulergine was also ineffective towards 5-HT. It can be concluded that hippocampal cholinergic terminals are endowed with inhibitory 5-HT receptors which appear to belong to the 5-HT1B subtype.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780847     DOI: 10.1016/0014-2999(86)90443-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

1.  Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors.

Authors:  I Cloëz-Tayarani; A Cardona; J C Rousselle; O Massot; L Edelman; G Fillion
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Inverse changes in raphe and cortical 5-HT1B receptor availability after acute tryptophan depletion in healthy human subjects.

Authors:  Stephen R Baldassarri; Eunkyung Park; Sjoerd J Finnema; Beata Planeta; Nabeel Nabulsi; Soheila Najafzadeh; Jim Ropchan; Yiyun Huang; Jonas Hannestad; Kathleen Maloney; Zubin Bhagwagar; Richard E Carson
Journal:  Synapse       Date:  2020-05-07       Impact factor: 2.562

3.  Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.

Authors:  P C Waldmeier; M Williams; P A Baumann; S Bischoff; M A Sills; R F Neale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

4.  Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.

Authors:  Katarina Varnäs; Svante Nyberg; Per Karlsson; M Edward Pierson; Matts Kågedal; Zsolt Cselényi; Dennis McCarthy; Alan Xiao; Minli Zhang; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2011-01-15       Impact factor: 4.530

5.  5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.

Authors:  S M Molineaux; T M Jessell; R Axel; D Julius
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  5-Hydroxytryptamine 5-HT1B receptors inhibiting cyclic AMP accumulation in rat renal mesangial cells.

Authors:  P Schoeffter; J Pfeilschifter; I Bobirnac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

7.  Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors.

Authors:  K Matsuno; T Senda; K Matsunaga; S Mita; H Kaneto
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons.

Authors:  T J Feuerstein; O Gleichauf; G B Landwehrmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

9.  Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans.

Authors:  Jean-Dominique Gallezot; Nabeel Nabulsi; Alexander Neumeister; Beata Planeta-Wilson; Wendol A Williams; Tarun Singhal; Sunhee Kim; R Paul Maguire; Timothy McCarthy; J James Frost; Yiyun Huang; Yu-Shin Ding; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

10.  Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.

Authors:  A T Bruinvels; J M Palacios; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.